+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Platelet Aggregation Devices Market - Global Forecast 2026-2032- Product Image
Platelet Aggregation Devices Market - Global Forecast 2026-2032- Product Image
Sale

Platelet Aggregation Devices Market - Global Forecast 2026-2032

  • Report

  • 197 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 4968880
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Platelet Aggregation Devices Market is projected to reach USD 922.44 Million in 2026. It is expected to continue growing at a CAGR of 5.42%, reaching USD 1.26 Billion by 2032.

Platelet aggregation devices are core tools in hemostasis diagnostics, supporting the evaluation of platelet function in thrombosis risk, bleeding disorders, antiplatelet therapy response, perioperative assessment, transfusion medicine, and cardiovascular care. Demand is anchored by a verified clinical reality: cardiovascular diseases remain the leading cause of death globally according to the World Health Organization, while antiplatelet therapies are widely used in coronary artery disease, stroke prevention, and interventional cardiology.

The market spans light transmission aggregometry, whole-blood impedance aggregometry, point-of-care platelet function analyzers, microfluidic platforms, reagents, controls, and software-enabled interpretation systems. Growth is shaped by the need for faster, standardized, and reproducible platelet function testing in hospitals, reference laboratories, academic medical centers, clinical trial sites, and research environments.

Transformative Shifts in Platelet Function Testing

The competitive landscape is shifting from conventional standalone platelet aggregometers toward integrated platelet function testing ecosystems that combine automation, digital quality control, standardized reagents, audit-ready documentation, and connectivity with laboratory information systems. Light transmission aggregometry remains a reference method in specialized laboratories, but adoption of whole-blood and point-of-care platelet function systems is increasing where faster clinical decisions are required.

Regulatory expectations are also reshaping product strategy. In the United States, platelet function devices are governed through FDA medical device pathways, while Europe’s In Vitro Diagnostic Regulation has raised requirements for clinical evidence, post-market surveillance, performance evaluation, and technical documentation. These changes favor manufacturers with strong validation, traceability, cybersecurity, and quality management capabilities.

Cumulative Impact of AI on Platelet Aggregation Devices

Artificial intelligence is beginning to influence platelet aggregation devices through waveform analysis, automated pattern recognition, pre-analytical error detection, reagent performance monitoring, delta-check support, and clinical decision assistance. AI can help laboratories reduce interpretation variability, particularly where platelet aggregation curves require expert review, consistent quality control, and correlation with clinical history and medication exposure.

The most commercially viable AI applications will be those aligned with regulated software-as-a-medical-device frameworks, transparent model documentation, cybersecurity controls, data governance, and human-in-the-loop validation. Industry leaders should treat AI as an evidence-generating enhancement rather than a replacement for established platelet function testing methods, with emphasis on explainability, bias control, and real-world performance monitoring.

Key Regional Insights Across Major Healthcare Markets

Asia-Pacific is gaining importance as China, India, Japan, South Korea, Australia, and ASEAN health systems expand tertiary care, cardiovascular intervention capacity, and clinical laboratory infrastructure. The region’s large patient base, aging demographics in several economies, and rising burden of cardiovascular disease strengthen demand for platelet aggregation devices used in antiplatelet therapy monitoring, thrombosis assessment, inherited and acquired platelet disorder workups, and perioperative bleeding risk evaluation.

North America remains a high-value region because of advanced hospital networks, reference laboratories, interventional cardiology volumes, clinical research activity, and established regulatory pathways. Europe is shaped by IVDR compliance, evidence-based laboratory medicine, accreditation-driven quality systems, and adoption across Germany, France, Italy, Spain, and the United Kingdom. Latin America shows selective growth led by Brazil and Mexico as private hospitals and specialized laboratories expand hemostasis diagnostics, while the Middle East is supported by GCC hospital investment, tertiary care development, and national healthcare modernization. Africa remains underpenetrated but strategically relevant as diagnostic capacity, specialist training, and referral laboratory networks expand across major urban centers.

Key Group Insights for Strategic Market Prioritization

ASEAN markets are moving toward broader laboratory modernization, with demand concentrated in urban hospitals, teaching institutions, and private diagnostics networks where cardiovascular care and hematology services are improving. The GCC benefits from centralized procurement, advanced tertiary hospitals, medical tourism initiatives, and national healthcare transformation programs that support adoption of specialized hemostasis diagnostics, including platelet function testing for perioperative, cardiology, and transfusion applications.

The European Union is a quality-driven market where IVDR compliance, clinical performance evidence, accreditation, traceability, and interoperability influence purchasing decisions. BRICS countries offer scale, local manufacturing opportunities, expanding hospital infrastructure, and high cardiovascular disease burden, but pricing, reimbursement, and access vary widely by country and care setting. G7 markets remain innovation leaders with strong uptake of automation, digital connectivity, and validated laboratory workflows, while NATO countries create demand for standardized trauma, transfusion, and perioperative hemostasis capabilities in civilian, emergency preparedness, and defense-linked health systems.

Key Country Insights in Platelet Aggregation Device Adoption

The United States leads in advanced platelet function testing adoption due to strong cardiovascular care infrastructure, specialized coagulation laboratories, academic medical centers, clinical trial activity, and active medical device innovation. Canada emphasizes quality-assured diagnostics within provincial health systems, while Mexico and Brazil provide growth opportunities through private hospital networks, expanding cardiology services, improving laboratory capacity, and increasing use of specialized diagnostic testing in major urban centers.

In Europe, the United Kingdom, Germany, France, Italy, and Spain are important markets for automated platelet aggregation systems, standardized hemostasis testing, and guideline-aligned laboratory workflows, although IVDR readiness and evidence documentation are decisive factors for supplier selection. Russia remains relevant through large hospital networks and specialist care centers but faces procurement and supply complexity. In Asia-Pacific, China and India offer scale through expanding tertiary hospitals and cardiovascular programs, Japan and South Korea emphasize high-quality diagnostics, automation, and innovation, and Australia supports adoption through advanced clinical laboratory standards, accreditation practices, and strong hospital-based testing capabilities.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize clinically validated platelet aggregation devices that improve reproducibility, reduce turnaround time, and integrate smoothly with laboratory workflows. Investment in automation, reagent standardization, onboard quality controls, external quality assessment support, operator training, and service responsiveness can directly address long-standing variability in platelet function testing.

Manufacturers should build regulatory strategies early, especially for FDA submissions, EU IVDR compliance, cybersecurity, post-market performance monitoring, and AI-enabled software validation. Commercial teams should segment buyers by use case, including cardiovascular intervention, hematology, perioperative medicine, transfusion services, emergency care, and pharmaceutical research, rather than relying on a single broad laboratory message.

Research Methodology and Evidence Framework

This executive summary is developed using a structured secondary-research approach grounded in publicly available and authoritative sources, including health agency publications, medical device regulatory frameworks, clinical laboratory standards, peer-reviewed literature, and recognized cardiovascular, transfusion medicine, and hematology guidance. The analysis prioritizes verified disease burden, technology adoption drivers, regulatory requirements, laboratory workflow needs, and healthcare infrastructure trends.

Market interpretation is based on triangulation of clinical use cases, regional healthcare investment patterns, product categories, procurement dynamics, and regulatory developments. No unsupported market-size, market-share, or growth-rate claims are included; emphasis is placed on evidence-backed directional insights relevant to platelet aggregation devices, platelet function testing, and hemostasis diagnostics.

Conclusion: Outlook for Platelet Aggregation Devices

The platelet aggregation devices market is evolving as healthcare systems demand more reliable, faster, and standardized platelet function testing. Cardiovascular disease burden, antiplatelet therapy use, surgical risk management, transfusion decision support, and specialized hematology diagnostics provide durable clinical demand across mature and emerging healthcare systems.

Future competitive advantage will depend on validated automation, regulatory readiness, AI-assisted interpretation, workflow integration, reagent reliability, quality assurance, and regional commercialization discipline. Organizations that combine clinical credibility with scalable service models and evidence-backed product development will be best positioned to address opportunities across diverse healthcare markets.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Platelet Aggregation Devices Market, by Product Type
7.1. Introduction
7.2. Benchtop Instruments
7.3. Portable Instruments
8. Platelet Aggregation Devices Market, by Test Type
8.1. Introduction
8.2. Flow Cytometry
8.2.1. Direct Flow Cytometry
8.2.2. Functional Flow Cytometry
8.3. Impedance Aggregometry
8.3.1. Platelet Rich Plasma Impedance
8.3.2. Whole Blood Impedance
8.4. Light Transmission Aggregometry
8.4.1. Optical Density Assays
8.4.2. Turbidimetric Assays
9. Platelet Aggregation Devices Market, by Modality
9.1. Introduction
9.2. In Vitro Assays
9.2.1. Aggregometry Systems
9.2.2. Impedance Systems
9.3. Point Of Care Systems
9.3.1. Cartridge-Based Systems
9.3.2. Handheld Devices
10. Platelet Aggregation Devices Market, by End User
10.1. Introduction
10.2. Academic Institutions
10.2.1. Teaching Hospitals
10.2.2. Universities
10.3. Diagnostic Laboratories
10.3.1. Central Laboratories
10.3.2. Point-Of-Care Laboratories
10.4. Hospitals
10.4.1. Community Hospitals
10.4.2. Tertiary Hospitals
10.5. Research Institutes
10.5.1. Biotechnology Firms
10.5.2. Pharmaceutical Companies
11. Platelet Aggregation Devices Market, by Region
11.1. Asia-Pacific
11.2. Europe
11.3. North America
11.4. Latin America
11.5. Africa
11.6. Middle East
12. Platelet Aggregation Devices Market, by Group
12.1. NATO
12.2. G7
12.3. BRICS
12.4. European Union
12.5. ASEAN
12.6. GCC
13. Platelet Aggregation Devices Market, by Country
13.1. China
13.2. United States
13.3. Japan
13.4. India
13.5. Germany
13.6. United Kingdom
13.7. Australia
13.8. France
13.9. South Korea
13.10. Italy
13.11. Canada
13.12. Russia
13.13. Brazil
13.14. Mexico
13.15. Spain
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. FPNV Positioning Matrix, 2025
14.3. Market Concentration Analysis, 2025
14.3.1. Concentration Ratio (CR)
14.3.2. Herfindahl Hirschman Index (HHI)
14.4. Recent Developments & Impact Analysis, 2025
14.5. Product Portfolio Analysis, 2025
14.6. Benchmarking Analysis, 2025
15. Company Profiles
15.1. Bio/Data Corporation
15.2. Chrono-Log Corporation
15.3. Diagnostica Stago S.A.S.
15.4. Drucker Diagnostics
15.5. F. Hoffmann-La Roche AG
15.6. Fluxion Biosciences, Inc.
15.7. Haemochrom Diagnostica GmbH
15.8. Haemonetics Corporation
15.9. Hart Biologicals Ltd
15.10. Helena Laboratories Corporation
15.11. Sarstedt AG & Co. KG
15.12. Sekisui Diagnostics, LLC
15.13. Sentinel CH. S.p.A.
15.14. Siemens Healthineers AG
15.15. Sienco, Inc.
15.16. Sysmex Corporation
15.17. Taiyo Corporation
15.18. Thermo Fisher Scientific Inc.
15.19. WerfenLife S.A.
List of Figures
FIGURE 1. GLOBAL PLATELET AGGREGATION DEVICES MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL PLATELET AGGREGATION DEVICES MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL PLATELET AGGREGATION DEVICES MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL PLATELET AGGREGATION DEVICES MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY TEST TYPE, 2025 VS 2032 (%)
FIGURE 9. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY TEST TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY MODALITY, 2025 VS 2032 (%)
FIGURE 11. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY MODALITY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 13. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 15. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 17. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 19. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL PLATELET AGGREGATION DEVICES MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 21. GLOBAL PLATELET AGGREGATION DEVICES MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL PLATELET AGGREGATION DEVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL BENCHTOP INSTRUMENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL BENCHTOP INSTRUMENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL BENCHTOP INSTRUMENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL PORTABLE INSTRUMENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL PORTABLE INSTRUMENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL PORTABLE INSTRUMENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL FLOW CYTOMETRY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL FLOW CYTOMETRY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL FLOW CYTOMETRY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL DIRECT FLOW CYTOMETRY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL DIRECT FLOW CYTOMETRY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL DIRECT FLOW CYTOMETRY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL FUNCTIONAL FLOW CYTOMETRY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL FUNCTIONAL FLOW CYTOMETRY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL FUNCTIONAL FLOW CYTOMETRY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL IMPEDANCE AGGREGOMETRY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL IMPEDANCE AGGREGOMETRY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL IMPEDANCE AGGREGOMETRY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL PLATELET RICH PLASMA IMPEDANCE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL PLATELET RICH PLASMA IMPEDANCE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL PLATELET RICH PLASMA IMPEDANCE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL WHOLE BLOOD IMPEDANCE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL WHOLE BLOOD IMPEDANCE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL WHOLE BLOOD IMPEDANCE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL LIGHT TRANSMISSION AGGREGOMETRY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL LIGHT TRANSMISSION AGGREGOMETRY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL LIGHT TRANSMISSION AGGREGOMETRY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL OPTICAL DENSITY ASSAYS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL OPTICAL DENSITY ASSAYS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL OPTICAL DENSITY ASSAYS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL TURBIDIMETRIC ASSAYS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL TURBIDIMETRIC ASSAYS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL TURBIDIMETRIC ASSAYS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY MODALITY, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL IN VITRO ASSAYS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL IN VITRO ASSAYS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL IN VITRO ASSAYS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL AGGREGOMETRY SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL AGGREGOMETRY SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL AGGREGOMETRY SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL IMPEDANCE SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL IMPEDANCE SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL IMPEDANCE SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL POINT OF CARE SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL POINT OF CARE SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL POINT OF CARE SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL CARTRIDGE-BASED SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL CARTRIDGE-BASED SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL CARTRIDGE-BASED SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL HANDHELD DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL HANDHELD DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL HANDHELD DEVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL ACADEMIC INSTITUTIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL ACADEMIC INSTITUTIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL ACADEMIC INSTITUTIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL TEACHING HOSPITALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL TEACHING HOSPITALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL TEACHING HOSPITALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL UNIVERSITIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL UNIVERSITIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL UNIVERSITIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL CENTRAL LABORATORIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL CENTRAL LABORATORIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL CENTRAL LABORATORIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL POINT-OF-CARE LABORATORIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL POINT-OF-CARE LABORATORIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL POINT-OF-CARE LABORATORIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL COMMUNITY HOSPITALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL COMMUNITY HOSPITALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL COMMUNITY HOSPITALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL TERTIARY HOSPITALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL TERTIARY HOSPITALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL TERTIARY HOSPITALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL BIOTECHNOLOGY FIRMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL BIOTECHNOLOGY FIRMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 90. GLOBAL BIOTECHNOLOGY FIRMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 91. GLOBAL PHARMACEUTICAL COMPANIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 92. GLOBAL PHARMACEUTICAL COMPANIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 93. GLOBAL PHARMACEUTICAL COMPANIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 94. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 95. ASIA-PACIFIC PLATELET AGGREGATION DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 96. ASIA-PACIFIC PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 97. ASIA-PACIFIC PLATELET AGGREGATION DEVICES MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 98. ASIA-PACIFIC PLATELET AGGREGATION DEVICES MARKET SIZE, BY FLOW CYTOMETRY, 2017-2032 (USD MILLION)
TABLE 99. ASIA-PACIFIC PLATELET AGGREGATION DEVICES MARKET SIZE, BY IMPEDANCE AGGREGOMETRY, 2017-2032 (USD MILLION)
TABLE 100. ASIA-PACIFIC PLATELET AGGREGATION DEVICES MARKET SIZE, BY LIGHT TRANSMISSION AGGREGOMETRY, 2017-2032 (USD MILLION)
TABLE 101. ASIA-PACIFIC PLATELET AGGREGATION DEVICES MARKET SIZE, BY MODALITY, 2017-2032 (USD MILLION)
TABLE 102. ASIA-PACIFIC PLATELET AGGREGATION DEVICES MARKET SIZE, BY IN VITRO ASSAYS, 2017-2032 (USD MILLION)
TABLE 103. ASIA-PACIFIC PLATELET AGGREGATION DEVICES MARKET SIZE, BY POINT OF CARE SYSTEMS, 2017-2032 (USD MILLION)
TABLE 104. ASIA-PACIFIC PLATELET AGGREGATION DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 105. ASIA-PACIFIC PLATELET AGGREGATION DEVICES MARKET SIZE, BY ACADEMIC INSTITUTIONS, 2017-2032 (USD MILLION)
TABLE 106. ASIA-PACIFIC PLATELET AGGREGATION DEVICES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2017-2032 (USD MILLION)
TABLE 107. ASIA-PACIFIC PLATELET AGGREGATION DEVICES MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 108. ASIA-PACIFIC PLATELET AGGREGATION DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, 2017-2032 (USD MILLION)
TABLE 109. EUROPE PLATELET AGGREGATION DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 110. EUROPE PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 111. EUROPE PLATELET AGGREGATION DEVICES MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 112. EUROPE PLATELET AGGREGATION DEVICES MARKET SIZE, BY FLOW CYTOMETRY, 2017-2032 (USD MILLION)
TABLE 113. EUROPE PLATELET AGGREGATION DEVICES MARKET SIZE, BY IMPEDANCE AGGREGOMETRY, 2017-2032 (USD MILLION)
TABLE 114. EUROPE PLATELET AGGREGATION DEVICES MARKET SIZE, BY LIGHT TRANSMISSION AGGREGOMETRY, 2017-2032 (USD MILLION)
TABLE 115. EUROPE PLATELET AGGREGATION DEVICES MARKET SIZE, BY MODALITY, 2017-2032 (USD MILLION)
TABLE 116. EUROPE PLATELET AGGREGATION DEVICES MARKET SIZE, BY IN VITRO ASSAYS, 2017-2032 (USD MILLION)
TABLE 117. EUROPE PLATELET AGGREGATION DEVICES MARKET SIZE, BY POINT OF CARE SYSTEMS, 2017-2032 (USD MILLION)
TABLE 118. EUROPE PLATELET AGGREGATION DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 119. EUROPE PLATELET AGGREGATION DEVICES MARKET SIZE, BY ACADEMIC INSTITUTIONS, 2017-2032 (USD MILLION)
TABLE 120. EUROPE PLATELET AGGREGATION DEVICES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2017-2032 (USD MILLION)
TABLE 121. EUROPE PLATELET AGGREGATION DEVICES MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 122. EUROPE PLATELET AGGREGATION DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, 2017-2032 (USD MILLION)
TABLE 123. NORTH AMERICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 124. NORTH AMERICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 125. NORTH AMERICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 126. NORTH AMERICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY FLOW CYTOMETRY, 2017-2032 (USD MILLION)
TABLE 127. NORTH AMERICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY IMPEDANCE AGGREGOMETRY, 2017-2032 (USD MILLION)
TABLE 128. NORTH AMERICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY LIGHT TRANSMISSION AGGREGOMETRY, 2017-2032 (USD MILLION)
TABLE 129. NORTH AMERICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY MODALITY, 2017-2032 (USD MILLION)
TABLE 130. NORTH AMERICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY IN VITRO ASSAYS, 2017-2032 (USD MILLION)
TABLE 131. NORTH AMERICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY POINT OF CARE SYSTEMS, 2017-2032 (USD MILLION)
TABLE 132. NORTH AMERICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 133. NORTH AMERICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY ACADEMIC INSTITUTIONS, 2017-2032 (USD MILLION)
TABLE 134. NORTH AMERICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2017-2032 (USD MILLION)
TABLE 135. NORTH AMERICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 136. NORTH AMERICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, 2017-2032 (USD MILLION)
TABLE 137. LATIN AMERICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 138. LATIN AMERICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 139. LATIN AMERICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 140. LATIN AMERICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY FLOW CYTOMETRY, 2017-2032 (USD MILLION)
TABLE 141. LATIN AMERICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY IMPEDANCE AGGREGOMETRY, 2017-2032 (USD MILLION)
TABLE 142. LATIN AMERICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY LIGHT TRANSMISSION AGGREGOMETRY, 2017-2032 (USD MILLION)
TABLE 143. LATIN AMERICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY MODALITY, 2017-2032 (USD MILLION)
TABLE 144. LATIN AMERICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY IN VITRO ASSAYS, 2017-2032 (USD MILLION)
TABLE 145. LATIN AMERICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY POINT OF CARE SYSTEMS, 2017-2032 (USD MILLION)
TABLE 146. LATIN AMERICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 147. LATIN AMERICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY ACADEMIC INSTITUTIONS, 2017-2032 (USD MILLION)
TABLE 148. LATIN AMERICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2017-2032 (USD MILLION)
TABLE 149. LATIN AMERICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 150. LATIN AMERICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, 2017-2032 (USD MILLION)
TABLE 151. AFRICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 152. AFRICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 153. AFRICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 154. AFRICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY FLOW CYTOMETRY, 2017-2032 (USD MILLION)
TABLE 155. AFRICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY IMPEDANCE AGGREGOMETRY, 2017-2032 (USD MILLION)
TABLE 156. AFRICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY LIGHT TRANSMISSION AGGREGOMETRY, 2017-2032 (USD MILLION)
TABLE 157. AFRICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY MODALITY, 2017-2032 (USD MILLION)
TABLE 158. AFRICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY IN VITRO ASSAYS, 2017-2032 (USD MILLION)
TABLE 159. AFRICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY POINT OF CARE SYSTEMS, 2017-2032 (USD MILLION)
TABLE 160. AFRICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 161. AFRICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY ACADEMIC INSTITUTIONS, 2017-2032 (USD MILLION)
TABLE 162. AFRICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2017-2032 (USD MILLION)
TABLE 163. AFRICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 164. AFRICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, 2017-2032 (USD MILLION)
TABLE 165. MIDDLE EAST PLATELET AGGREGATION DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 166. MIDDLE EAST PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 167. MIDDLE EAST PLATELET AGGREGATION DEVICES MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 168. MIDDLE EAST PLATELET AGGREGATION DEVICES MARKET SIZE, BY FLOW CYTOMETRY, 2017-2032 (USD MILLION)
TABLE 169. MIDDLE EAST PLATELET AGGREGATION DEVICES MARKET SIZE, BY IMPEDANCE AGGREGOMETRY, 2017-2032 (USD MILLION)
TABLE 170. MIDDLE EAST PLATELET AGGREGATION DEVICES MARKET SIZE, BY LIGHT TRANSMISSION AGGREGOMETRY, 2017-2032 (USD MILLION)
TABLE 171. MIDDLE EAST PLATELET AGGREGATION DEVICES MARKET SIZE, BY MODALITY, 2017-2032 (USD MILLION)
TABLE 172. MIDDLE EAST PLATELET AGGREGATION DEVICES MARKET SIZE, BY IN VITRO ASSAYS, 2017-2032 (USD MILLION)
TABLE 173. MIDDLE EAST PLATELET AGGREGATION DEVICES MARKET SIZE, BY POINT OF CARE SYSTEMS, 2017-2032 (USD MILLION)
TABLE 174. MIDDLE EAST PLATELET AGGREGATION DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 175. MIDDLE EAST PLATELET AGGREGATION DEVICES MARKET SIZE, BY ACADEMIC INSTITUTIONS, 2017-2032 (USD MILLION)
TABLE 176. MIDDLE EAST PLATELET AGGREGATION DEVICES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2017-2032 (USD MILLION)
TABLE 177. MIDDLE EAST PLATELET AGGREGATION DEVICES MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 178. MIDDLE EAST PLATELET AGGREGATION DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, 2017-2032 (USD MILLION)
TABLE 179. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 180. NATO PLATELET AGGREGATION DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 181. NATO PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 182. NATO PLATELET AGGREGATION DEVICES MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 183. NATO PLATELET AGGREGATION DEVICES MARKET SIZE, BY FLOW CYTOMETRY, 2017-2032 (USD MILLION)
TABLE 184. NATO PLATELET AGGREGATION DEVICES MARKET SIZE, BY IMPEDANCE AGGREGOMETRY, 2017-2032 (USD MILLION)
TABLE 185. NATO PLATELET AGGREGATION DEVICES MARKET SIZE, BY LIGHT TRANSMISSION AGGREGOMETRY, 2017-2032 (USD MILLION)
TABLE 186. NATO PLATELET AGGREGATION DEVICES MARKET SIZE, BY MODALITY, 2017-2032 (USD MILLION)
TABLE 187. NATO PLATELET AGGREGATION DEVICES MARKET SIZE, BY IN VITRO ASSAYS, 2017-2032 (USD MILLION)
TABLE 188. NATO PLATELET AGGREGATION DEVICES MARKET SIZE, BY POINT OF CARE SYSTEMS, 2017-2032 (USD MILLION)
TABLE 189. NATO PLATELET AGGREGATION DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 190. NATO PLATELET AGGREGATION DEVICES MARKET SIZE, BY ACADEMIC INSTITUTIONS, 2017-2032 (USD MILLION)
TABLE 191. NATO PLATELET AGGREGATION DEVICES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2017-2032 (USD MILLION)
TABLE 192. NATO PLATELET AGGREGATION DEVICES MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 193. NATO PLATELET AGGREGATION DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, 2017-2032 (USD MILLION)
TABLE 194. G7 PLATELET AGGREGATION DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 195. G7 PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 196. G7 PLATELET AGGREGATION DEVICES MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 197. G7 PLATELET AGGREGATION DEVICES MARKET SIZE, BY FLOW CYTOMETRY, 2017-2032 (USD MILLION)
TABLE 198. G7 PLATELET AGGREGATION DEVICES MARKET SIZE, BY IMPEDANCE AGGREGOMETRY, 2017-2032 (USD MILLION)
TABLE 199. G7 PLATELET AGGREGATION DEVICES MARKET SIZE, BY LIGHT TRANSMISSION AGGREGOMETRY, 2017-2032 (USD MILLION)
TABLE 200. G7 PLATELET AGGREGATION DEVICES MARKET SIZE, BY MODALITY, 2017-2032 (USD MILLION)
TABLE 201. G7 PLATELET AGGREGATION DEVICES MARKET SIZE, BY IN VITRO ASSAYS, 2017-2032 (USD MILLION)
TABLE 202. G7 PLATELET AGGREGATION DEVICES MARKET SIZE, BY POINT OF CARE SYSTEMS, 2017-2032 (USD MILLION)
TABLE 203. G7 PLATELET AGGREGATION DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 204. G7 PLATELET AGGREGATION DEVICES MARKET SIZE, BY ACADEMIC INSTITUTIONS, 2017-2032 (USD MILLION)
TABLE 205. G7 PLATELET AGGREGATION DEVICES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2017-2032 (USD MILLION)
TABLE 206. G7 PLATELET AGGREGATION DEVICES MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 207. G7 PLATELET AGGREGATION DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, 2017-2032 (USD MILLION)
TABLE 208. BRICS PLATELET AGGREGATION DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 209. BRICS PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 210. BRICS PLATELET AGGREGATION DEVICES MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 211. BRICS PLATELET AGGREGATION DEVICES MARKET SIZE, BY FLOW CYTOMETRY, 2017-2032 (USD MILLION)
TABLE 212. BRICS PLATELET AGGREGATION DEVICES MARKET SIZE, BY IMPEDANCE AGGREGOMETRY, 2017-2032 (USD MILLION)
TABLE 213. BRICS PLATELET AGGREGATION DEVICES MARKET SIZE, BY LIGHT TRANSMISSION AGGREGOMETRY, 2017-2032 (USD MILLION)
TABLE 214. BRICS PLATELET AGGREGATION DEVICES MARKET SIZE, BY MODALITY, 2017-2032 (USD MILLION)
TABLE 215. BRICS PLATELET AGGREGATION DEVICES MARKET SIZE, BY IN VITRO ASSAYS, 2017-2032 (USD MILLION)
TABLE 216. BRICS PLATELET AGGREGATION DEVICES MARKET SIZE, BY POINT OF CARE SYSTEMS, 2017-2032 (USD MILLION)
TABLE 217. BRICS PLATELET AGGREGATION DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 218. BRICS PLATELET AGGREGATION DEVICES MARKET SIZE, BY ACADEMIC INSTITUTIONS, 2017-2032 (USD MILLION)
TABLE 219. BRICS PLATELET AGGREGATION DEVICES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2017-2032 (USD MILLION)
TABLE 220. BRICS PLATELET AGGREGATION DEVICES MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 221. BRICS PLATELET AGGREGATION DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, 2017-2032 (USD MILLION)
TABLE 222. EUROPEAN UNION PLATELET AGGREGATION DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 223. EUROPEAN UNION PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 224. EUROPEAN UNION PLATELET AGGREGATION DEVICES MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 225. EUROPEAN UNION PLATELET AGGREGATION DEVICES MARKET SIZE, BY FLOW CYTOMETRY, 2017-2032 (USD MILLION)
TABLE 226. EUROPEAN UNION PLATELET AGGREGATION DEVICES MARKET SIZE, BY IMPEDANCE AGGREGOMETRY, 2017-2032 (USD MILLION)
TABLE 227. EUROPEAN UNION PLATELET AGGREGATION DEVICES MARKET SIZE, BY LIGHT TRANSMISSION AGGREGOMETRY, 2017-2032 (USD MILLION)
TABLE 228. EUROPEAN UNION PLATELET AGGREGATION DEVICES MARKET SIZE, BY MODALITY, 2017-2032 (USD MILLION)
TABLE 229. EUROPEAN UNION PLATELET AGGREGATION DEVICES MARKET SIZE, BY IN VITRO ASSAYS, 2017-2032 (USD MILLION)
TABLE 230. EUROPEAN UNION PLATELET AGGREGATION DEVICES MARKET SIZE, BY POINT OF CARE SYSTEMS, 2017-2032 (USD MILLION)
TABLE 231. EUROPEAN UNION PLATELET AGGREGATION DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 232. EUROPEAN UNION PLATELET AGGREGATION DEVICES MARKET SIZE, BY ACADEMIC INSTITUTIONS, 2017-2032 (USD MILLION)
TABLE 233. EUROPEAN UNION PLATELET AGGREGATION DEVICES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2017-2032 (USD MILLION)
TABLE 234. EUROPEAN UNION PLATELET AGGREGATION DEVICES MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 235. EUROPEAN UNION PLATELET AGGREGATION DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, 2017-2032 (USD MILLION)
TABLE 236. ASEAN PLATELET AGGREGATION DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 237. ASEAN PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 238. ASEAN PLATELET AGGREGATION DEVICES MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 239. ASEAN PLATELET AGGREGATION DEVICES MARKET SIZE, BY FLOW CYTOMETRY, 2017-2032 (USD MILLION)
TABLE 240. ASEAN PLATELET AGGREGATION DEVICES MARKET SIZE, BY IMPEDANCE AGGREGOMETRY, 2017-2032 (USD MILLION)
TABLE 241. ASEAN PLATELET AGGREGATION DEVICES MARKET SIZE, BY LIGHT TRANSMISSION AGGREGOMETRY, 2017-2032 (USD MILLION)
TABLE 242. ASEAN PLATELET AGGREGATION DEVICES MARKET SIZE, BY MODALITY, 2017-2032 (USD MILLION)
TABLE 243. ASEAN PLATELET AGGREGATION DEVICES MARKET SIZE, BY IN VITRO ASSAYS, 2017-2032 (USD MILLION)
TABLE 244. ASEAN PLATELET AGGREGATION DEVICES MARKET SIZE, BY POINT OF CARE SYSTEMS, 2017-2032 (USD MILLION)
TABLE 245. ASEAN PLATELET AGGREGATION DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 246. ASEAN PLATELET AGGREGATION DEVICES MARKET SIZE, BY ACADEMIC INSTITUTIONS, 2017-2032 (USD MILLION)
TABLE 247. ASEAN PLATELET AGGREGATION DEVICES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2017-2032 (USD MILLION)
TABLE 248. ASEAN PLATELET AGGREGATION DEVICES MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 249. ASEAN PLATELET AGGREGATION DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, 2017-2032 (USD MILLION)
TABLE 250. GCC PLATELET AGGREGATION DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 251. GCC PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 252. GCC PLATELET AGGREGATION DEVICES MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 253. GCC PLATELET AGGREGATION DEVICES MARKET SIZE, BY FLOW CYTOMETRY, 2017-2032 (USD MILLION)
TABLE 254. GCC PLATELET AGGREGATION DEVICES MARKET SIZE, BY IMPEDANCE AGGREGOMETRY, 2017-2032 (USD MILLION)
TABLE 255. GCC PLATELET AGGREGATION DEVICES MARKET SIZE, BY LIGHT TRANSMISSION AGGREGOMETRY, 2017-2032 (USD MILLION)
TABLE 256. GCC PLATELET AGGREGATION DEVICES MARKET SIZE, BY MODALITY, 2017-2032 (USD MILLION)
TABLE 257. GCC PLATELET AGGREGATION DEVICES MARKET SIZE, BY IN VITRO ASSAYS, 2017-2032 (USD MILLION)
TABLE 258. GCC PLATELET AGGREGATION DEVICES MARKET SIZE, BY POINT OF CARE SYSTEMS, 2017-2032 (USD MILLION)
TABLE 259. GCC PLATELET AGGREGATION DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 260. GCC PLATELET AGGREGATION DEVICES MARKET SIZE, BY ACADEMIC INSTITUTIONS, 2017-2032 (USD MILLION)
TABLE 261. GCC PLATELET AGGREGATION DEVICES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2017-2032 (USD MILLION)
TABLE 262. GCC PLATELET AGGREGATION DEVICES MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 263. GCC PLATELET AGGREGATION DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, 2017-2032 (USD MILLION)
TABLE 264. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 265. CHINA PLATELET AGGREGATION DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 266. CHINA PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 267. CHINA PLATELET AGGREGATION DEVICES MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 268. CHINA PLATELET AGGREGATION DEVICES MARKET SIZE, BY FLOW CYTOMETRY, 2017-2032 (USD MILLION)
TABLE 269. CHINA PLATELET AGGREGATION DEVICES MARKET SIZE, BY IMPEDANCE AGGREGOMETRY, 2017-2032 (USD MILLION)
TABLE 270. CHINA PLATELET AGGREGATION DEVICES MARKET SIZE, BY LIGHT TRANSMISSION AGGREGOMETRY, 2017-2032 (USD MILLION)
TABLE 271. CHINA PLATELET AGGREGATION DEVICES MARKET SIZE, BY MODALITY, 2017-2032 (USD MILLION)
TABLE 272. CHINA PLATELET AGGREGATION DEVICES MARKET SIZE, BY IN VITRO ASSAYS, 2017-2032 (USD MILLION)
TABLE 273. CHINA PLATELET AGGREGATION DEVICES MARKET SIZE, BY POINT OF CARE SYSTEMS, 2017-2032 (USD MILLION)
TABLE 274. CHINA PLATELET AGGREGATION DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 275. CHINA PLATELET AGGREGATION DEVICES MARKET SIZE, BY ACADEMIC INSTITUTIONS, 2017-2032 (USD MILLION)
TABLE 276. CHINA PLATELET AGGREGATION DEVICES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2017-2032 (USD MILLION)
TABLE 277. CHINA PLATELET AGGREGATION DEVICES MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 278. CHINA PLATELET AGGREGATION DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, 2017-2032 (USD MILLION)
TABLE 279. UNITED STATES PLATELET AGGREGATION DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 280. UNITED STATES PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 281. UNITED STATES PLATELET AGGREGATION DEVICES MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 282. UNITED STATES PLATELET AGGREGATION DEVICES MARKET SIZE, BY FLOW CYTOMETRY, 2017-2032 (USD MILLION)
TABLE 283. UNITED STATES PLATELET AGGREGATION DEVICES MARKET SIZE, BY IMPEDANCE AGGREGOMETRY, 2017-2032 (USD MILLION)
TABLE 284. UNITED STATES PLATELET AGGREGATION DEVICES MARKET SIZE, BY LIGHT TRANSMISSION AGGREGOMETRY, 2017-2032 (USD MILLION)
TABLE 285. UNITED STATES PLATELET AGGREGATION DEVICES MARKET SIZE, BY MODALITY, 2017-2032 (USD MILLION)
TABLE 286. UNITED STATES PLATELET AGGREGATION DEVICES MARKET SIZE, BY IN VITRO ASSAYS, 2017-2032 (USD MILLION)
TABLE 287. UNITED STATES PLATELET AGGREGATION DEVICES MARKET SIZE, BY POINT OF CARE SYSTEMS, 2017-2032 (USD MILLION)
TABLE 288. UNITED STATES PLATELET AGGREGATION DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 289. UNITED STATES PLATELET AGGREGATION DEVICES MARKET SIZE, BY ACADEMIC INSTITUTIONS, 2017-2032 (USD MILLION)
TABLE 290. UNITED STATES PLATELET AGGREGATION DEVICES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2017-2032 (USD MILLION)
TABLE 291. UNITED STATES PLATELET AGGREGATION DEVICES MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 292. UNITED STATES PLATELET AGGREGATION DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, 2017-2032 (USD MILLION)
TABLE 293. JAPAN PLATELET AGGREGATION DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 294. JAPAN PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 295. JAPAN PLATELET AGGREGATION DEVICES MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 296. JAPAN PLATELET AGGREGATION DEVICES MARKET SIZE, BY FLOW CYTOMETRY, 2017-2032 (USD MILLION)
TABLE 297. JAPAN PLATELET AGGREGATION DEVICES MARKET SIZE, BY IMPEDANCE AGGREGOMETRY, 2017-2032 (USD MILLION)
TABLE 298. JAPAN PLATELET AGGREGATION DEVICES MARKET SIZE, BY LIGHT TRANSMISSION AGGREGOMETRY, 2017-2032 (USD MILLION)
TABLE 299. JAPAN PLATELET AGGREGATION DEVICES MARKET SIZE, BY MODALITY, 2017-2032 (USD MILLION)
TABLE 300. JAPAN PLATELET AGGREGATION DEVICES MARKET SIZE, BY IN VITRO ASSAYS, 2017-2032 (USD MILLION)
TABLE 301. JAPAN PLATELET AGGREGATION DEVICES MARKET SIZE, BY POINT OF CARE SYSTEMS, 2017-2032 (USD MILLION)
TABLE 302. JAPAN PLATELET AGGREGATION DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 303. JAPAN PLATELET AGGREGATION DEVICES MARKET SIZE, BY ACADEMIC INSTITUTIONS, 2017-2032 (USD MILLION)
TABLE 304. JAPAN PLATELET AGGREGATION DEVICES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2017-2032 (USD MILLION)
TABLE 305. JAPAN PLATELET AGGREGATION DEVICES MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 306. JAPAN PLATELET AGGREGATION DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, 2017-2032 (USD MILLION)
TABLE 307. INDIA PLATELET AGGREGATION DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 308. INDIA PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 309. INDIA PLATELET AGGREGATION DEVICES MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 310. INDIA PLATELET AGGREGATION DEVICES MARKET SIZE, BY FLOW CYTOMETRY, 2017-2032 (USD MILLION)
TABLE 311. INDIA PLATELET AGGREGATION DEVICES MARKET SIZE, BY IMPEDANCE AGGREGOMETRY, 2017-2032 (USD MILLION)
TABLE 312. INDIA PLATELET AGGREGATION DEVICES MARKET SIZE, BY LIGHT TRANSMISSION AGGREGOMETRY, 2017-2032 (USD MILLION)
TABLE 313. INDIA PLATELET AGGREGATION DEVICES MARKET SIZE, BY MODALITY, 2017-2032 (USD MILLION)
TABLE 314. INDIA PLATELET AGGREGATION DEVICES MARKET SIZE, BY IN VITRO ASSAYS, 2017-2032 (USD MILLION)
TABLE 315. INDIA PLATELET AGGREGATION DEVICES MARKET SIZE, BY POINT OF CARE SYSTEMS, 2017-2032 (USD MILLION)
TABLE 316. INDIA PLATELET AGGREGATION DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 317. INDIA PLATELET AGGREGATION DEVICES MARKET SIZE, BY ACADEMIC INSTITUTIONS, 2017-2032 (USD MILLION)
TABLE 318. INDIA PLATELET AGGREGATION DEVICES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2017-2032 (USD MILLION)
TABLE 319. INDIA PLATELET AGGREGATION DEVICES MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 320. INDIA PLATELET AGGREGATION DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, 2017-2032 (USD MILLION)
TABLE 321. GERMANY PLATELET AGGREGATION DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 322. GERMANY PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 323. GERMANY PLATELET AGGREGATION DEVICES MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 324. GERMANY PLATELET AGGREGATION DEVICES MARKET SIZE, BY FLOW CYTOMETRY, 2017-2032 (USD MILLION)
TABLE 325. GERMANY PLATELET AGGREGATION DEVICES MARKET SIZE, BY IMPEDANCE AGGREGOMETRY, 2017-2032 (USD MILLION)
TABLE 326. GERMANY PLATELET AGGREGATION DEVICES MARKET SIZE, BY LIGHT TRANSMISSION AGGREGOMETRY, 2017-2032 (USD MILLION)
TABLE 327. GERMANY PLATELET AGGREGATION DEVICES MARKET SIZE, BY MODALITY, 2017-2032 (

Companies Mentioned

  • Bio/Data Corporation
  • Chrono-Log Corporation
  • Diagnostica Stago S.A.S.
  • Drucker Diagnostics
  • F. Hoffmann-La Roche AG
  • Fluxion Biosciences, Inc.
  • Haemochrom Diagnostica GmbH
  • Haemonetics Corporation
  • Hart Biologicals Ltd
  • Helena Laboratories Corporation
  • Sarstedt AG & Co. KG
  • Sekisui Diagnostics, LLC
  • Sentinel CH. S.p.A.
  • Siemens Healthineers AG
  • Sienco, Inc.
  • Sysmex Corporation
  • Taiyo Corporation
  • Thermo Fisher Scientific Inc.
  • WerfenLife S.A.

Table Information

Report AttributeDetails
No. of Pages197
PublishedSeptember 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 922.44 Million
Forecasted Market Value ( USD ) by 2032 $ 1260 Million
Compound Annual Growth Rate5.4%
Regions CoveredGlobal
No. of Companies Mentioned19

Related Topics

Related Reports

Platelet Aggregation Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Platelet Aggregation Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 110 Pages
  • Global
From
Platelet Aggregation Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031 - Product Image

Platelet Aggregation Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

  • Report
  • 180 Pages
  • Global
From
Platelet Aggregation Devices - Global Strategic Business Report - Product Image

Platelet Aggregation Devices - Global Strategic Business Report

  • Report
  • 174 Pages
  • Global
From
Platelet Aggregation Devices Market Report 2026 - Product Image

Platelet Aggregation Devices Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Platelet Aggregation Devices Market Report by Product, Type, Application, End User, and Region 2026-2034 - Product Image

Platelet Aggregation Devices Market Report by Product, Type, Application, End User, and Region 2026-2034

  • Report
  • 146 Pages
  • Global
From

About the Platelet Aggregation Market

The Platelet Aggregation market is a segment of the Medical Devices industry that focuses on the diagnosis and treatment of cardiovascular diseases. Platelet Aggregation is a process in which platelets in the blood clump together to form a clot. Platelet Aggregation tests are used to diagnose and monitor conditions such as coronary artery disease, stroke, and deep vein thrombosis. Platelet Aggregation devices are used to measure the speed and strength of platelet aggregation in the blood. These devices are used in hospitals, clinics, and laboratories. The Platelet Aggregation market is driven by the increasing prevalence of cardiovascular diseases, technological advancements in platelet aggregation devices, and the growing demand for point-of-care testing. The market is expected to witness a steady growth in the coming years. Some of the major players in the Platelet Aggregation market include Siemens Healthineers, Abbott Laboratories, Roche Diagnostics, Sysmex Corporation, Helena Laboratories, and Bio/Data Corporation. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.